These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 25503158)

  • 1. Preoperative serum C-reactive protein and its prognostic significance in patients with stage III-IV colorectal cancer.
    Lumachi F; Basso SM; Santeufemia DA; Ermani M; Lo Re G; Chiara GB
    Anticancer Res; 2014 Dec; 34(12):7263-6. PubMed ID: 25503158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of C-reactive protein on prognosis of patients with colorectal carcinoma.
    Takasu C; Shimada M; Kurita N; Iwata T; Nishioka M; Morimoto S; Yoshikawa K; Miyatani T; Kashihara H; Utsunomiya T
    Hepatogastroenterology; 2013 May; 60(123):507-11. PubMed ID: 23635436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative C-reactive protein as a prognostic and therapeutic marker for colorectal cancer.
    Koike Y; Miki C; Okugawa Y; Yokoe T; Toiyama Y; Tanaka K; Inoue Y; Kusunoki M
    J Surg Oncol; 2008 Dec; 98(7):540-4. PubMed ID: 18937231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated preoperative serum C-reactive protein levels are associated with poor survival in patients with colorectal cancer.
    Shibutani M; Maeda K; Nagahara H; Ohtani H; Sugano K; Ikeya T; Kimura K; Amano R; Kubo N; Tanaka H; Muguruma K; Ohira M; Hirakawa K
    Hepatogastroenterology; 2014; 61(136):2236-40. PubMed ID: 25699359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-reactive protein: a biomarker of survival in patients with localized upper tract urothelial carcinoma treated with radical nephroureterectomy.
    Obata J; Kikuchi E; Tanaka N; Matsumoto K; Hayakawa N; Ide H; Miyajima A; Nakagawa K; Oya M
    Urol Oncol; 2013 Nov; 31(8):1725-30. PubMed ID: 23141922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated C-reactive protein is associated with the tumor depth of invasion but not with disease recurrence in stage II and III colorectal cancer.
    Fujii T; Yajima R; Tabe Y; Yamaguchi S; Tsutsumi S; Asao T; Kuwano H
    Hepatogastroenterology; 2013 Sep; 60(126):1343-7. PubMed ID: 23933927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammation-based prognostic system predicts postoperative survival of colorectal cancer patients with a normal preoperative serum level of carcinoembryonic antigen.
    Ishizuka M; Nagata H; Takagi K; Iwasaki Y; Kubota K
    Ann Surg Oncol; 2012 Oct; 19(11):3422-31. PubMed ID: 22576063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-reactive protein is a negative independent factor in patients with stage IV colorectal cancer undergoing oxaliplatin-based chemotherapy.
    Fukuchi M; Kuwabara K; Tsuji Y; Baba H; Ishibashi K; Chika N; Hatano S; Matsuzawa T; Kumamoto K; Kumagai Y; Mochiki E; Ishida H
    Anticancer Res; 2013 Nov; 33(11):5051-5. PubMed ID: 24222149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.
    Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Lamerz R
    Anticancer Res; 2000; 20(6D):5195-8. PubMed ID: 11326694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical significance of C-reactive protein in patients with stage I non-small cell lung cancer].
    Shen L; Li ZM; Lu S
    Zhonghua Zhong Liu Za Zhi; 2011 Jun; 33(6):442-6. PubMed ID: 21875485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of nutritional and inflammatory status of advanced colorectal cancer patients and its correlation with survival.
    Read JA; Choy ST; Beale PJ; Clarke SJ
    Nutr Cancer; 2006; 55(1):78-85. PubMed ID: 16965244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophage inflammatory protein-3 alpha (MIP-3a) is a novel serum prognostic marker in patients with colorectal cancer.
    Iwata T; Tanaka K; Inoue Y; Toiyama Y; Hiro J; Fujikawa H; Okugawa Y; Uchida K; Mohri Y; Kusunoki M
    J Surg Oncol; 2013 Feb; 107(2):160-6. PubMed ID: 22926691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preresection serum C-reactive protein measurement and survival among patients with resectable non-small cell lung cancer.
    Alifano M; Falcoz PE; Seegers V; Roche N; Schussler O; Younes M; Antonacci F; Forgez P; Dechartres A; Massard G; Damotte D; Régnard JF
    J Thorac Cardiovasc Surg; 2011 Nov; 142(5):1161-7. PubMed ID: 21872279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Significance of the C-Reactive Protein to Albumin Ratio for Survival After Surgery for Colorectal Cancer.
    Ishizuka M; Nagata H; Takagi K; Iwasaki Y; Shibuya N; Kubota K
    Ann Surg Oncol; 2016 Mar; 23(3):900-7. PubMed ID: 26530445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble CXCL16 in preoperative serum is a novel prognostic marker and predicts recurrence of liver metastases in colorectal cancer patients.
    Matsushita K; Toiyama Y; Tanaka K; Saigusa S; Hiro J; Uchida K; Inoue Y; Kusunoki M
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S518-27. PubMed ID: 21845497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Baseline serum C-reactive protein and death from colorectal cancer in the NHANES III cohort.
    Swede H; Hajduk AM; Sharma J; Rawal S; Rasool H; Vella AT; Tobet RE; Stevens RG
    Int J Cancer; 2014 Apr; 134(8):1862-70. PubMed ID: 24122448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of preoperative bowel obstruction in stage III colorectal cancer.
    Katoh H; Yamashita K; Wang G; Sato T; Nakamura T; Watanabe M
    Ann Surg Oncol; 2011 Sep; 18(9):2432-41. PubMed ID: 21369738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is C-reactive protein a prognostic factor of colorectal cancer?
    Shiu YC; Lin JK; Huang CJ; Jiang JK; Wang LW; Huang HC; Yang SH
    Dis Colon Rectum; 2008 Apr; 51(4):443-9. PubMed ID: 18172726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of smoking in addition to established risk factors in patients with Dukes B and C colorectal cancer: a retrospective analysis.
    Diamantis N; Xynos ID; Amptulah S; Karadima M; Skopelitis H; Tsavaris N
    J BUON; 2013; 18(1):105-15. PubMed ID: 23613395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of serum C-reactive protein (CRP) as an independent prognostic factor for disease-free survival in patients with localised renal cell carcinoma (RCC).
    de Martino M; Klatte T; Seemann C; Waldert M; Haitel A; Schatzl G; Remzi M; Weibl P
    BJU Int; 2013 Jun; 111(8):E348-53. PubMed ID: 23495750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.